William S. Dalton
- Hematology top 0.2%
- Multiple Myeloma Research and Treatments 44
- Oncology top 0.2%
- Drug Transport and Resistance Mechanisms 21
- Cytokine Signaling Pathways and Interactions 16
- Cancer Research top 0.5%
- Immunology top 1%
- Molecular Biology top 0.5%
- Cancer therapeutics and mechanisms 21
- Protein Degradation and Inhibitors 15
- Cell death mechanisms and regulation 12
-
- Cancer Mechanisms and Therapy 10
-
- Cell Adhesion Molecules Research 10
- Co-authors
- Terry H. LandowskiLori HazlehurstKenneth H. ShainRichard JoveMark B. MeadsRobert A. GatenbyLynn C. MoscinskiDomenico Coppola
- Cited by
- HematologyOncologyCancer Research
- Journals
- Proceedings of the National Academy of Sciences (1 paper)Journal of Biological Chemistry (2 papers)Journal of Clinical Investigation (1 paper)
- Partner nations
- United StatesNetherlandsCanada
In The Last Decade
William S. Dalton
130 papers receiving 11.6k citations
Hit Papers
Peers
Comparison fields: 5 of 142
- Hematology 2.4k
- Oncology 5.7k
- Cancer Research 2.3k
- Immunology 2.3k
- Molecular Biology 6.8k
Countries citing papers authored by William S. Dalton
This map shows the geographic impact of William S. Dalton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by William S. Dalton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites William S. Dalton more than expected).
Fields of papers citing papers by William S. Dalton
This network shows the impact of papers produced by William S. Dalton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by William S. Dalton. The network helps show where William S. Dalton may publish in the future.
Co-authorship network
The 25 scholars most cited alongside William S. Dalton, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 2 | |
| 2 | 2012 | 69 | |
| 3 | 2009 | 90 | |
| 4 | 2009 | 33 | |
| 5 | 2009 | 23 | |
| 6 | Bone marrow stromal cells activate Stat3 and confer resistance to Bcr-Abl inhibitors in K562 CML cells | 2008 | 0 |
| 7 | 2008 | 37 | |
| 8 | 2005 | 114 | |
| 9 | 2004 | 30 | |
| 10 | Regulation of the innate and adaptive immune responses by Stat-3 signaling in tumor cellsbreakdown → | 2003 | 923 |
| 11 | 2003 | 162 | |
| 12 | 2001 | 132 | |
| 13 | 1999 | 284 | |
| 14 | Constitutive Activation of Stat3 Signaling Confers Resistance to Apoptosis in Human U266 Myeloma Cellsbreakdown → | 1999 | 1408 |
| 15 | 1997 | 192 | |
| 16 | 1997 | 22 | |
| 17 | 1994 | 15 | |
| 18 | 1993 | 69 | |
| 19 | 1989 | 20 | |
| 20 | Direct relation of DNA lesions in multidrug-resistant human myeloma cells to intracellular doxorubicin concentration. | 1988 | 25 |
About William S. Dalton
William S. Dalton is a scholar working on Hematology, Oncology and Immunology and Allergy, having authored 132 papers that have together received 11.8k indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (44 papers), Drug Transport and Resistance Mechanisms (21 papers), Cancer therapeutics and mechanisms (21 papers), Cytokine Signaling Pathways and Interactions (16 papers), Protein Degradation and Inhibitors (15 papers), Cell death mechanisms and regulation (12 papers), Cancer Mechanisms and Therapy (10 papers) and Cell Adhesion Molecules Research (10 papers). The work is most often cited by research in Hematology (2.4k citations), Oncology (5.7k citations) and Cancer Research (2.3k citations). William S. Dalton has collaborated with scholars based in United States, Netherlands and Canada. Frequent co-authors include Terry H. Landowski, Lori Hazlehurst, Kenneth H. Shain, Richard Jove, Mark B. Meads, Robert A. Gatenby, Lynn C. Moscinski, Domenico Coppola, Marc M. Oshiro and Robyn Catlett-Falcone. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Investigation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.